Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 400745
HGNC: 28819
Ensembl: ENSG00000189410
Variants:
dbSNP: 400745
ClinVar: 400745
TCGA: ENSG00000189410
COSMIC: SH2D5
RNA/Proteins
Expression (GTEx)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA445218 | Pancreatic Neoplasms | Disease | ClinicalAnnotation | associated | PD | 22838950 | |
| PA449748 | gemcitabine | Chemical | ClinicalAnnotation | associated | PD | 22838950 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37187527 | 2023 | Prognostic significance of SH2D5 expression in lung adenocarcinoma and its relation to immune cell infiltration. | 0 |
| 37187527 | 2023 | Prognostic significance of SH2D5 expression in lung adenocarcinoma and its relation to immune cell infiltration. | 0 |
| 30659097 | 2019 | Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction. | 15 |
| 30659097 | 2019 | Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction. | 15 |
| 20379614 | 2010 | Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. | 78 |
| 20379614 | 2010 | Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. | 78 |
Citation
Dessen P
SH2D5 (SH2 domain containing 5)
Atlas Genet Cytogenet Oncol Haematol. 2021-06-01
Online version: http://atlasgeneticsoncology.org/gene/58336/sh2d5-(sh2-domain-containing-5)
